Securities Class Actions – Page 30 – ClaimsFiler

Case Type: Securities Class Actions

Amdocs Limited, through its global subsidiaries, provides software and services to communications, cable and satellite, entertainment, and media industry service providers worldwide. Historically, the Company’s largest percentage of revenues come from its North American business, mostly the U.S., particularly from large customers including, among others, AT&T Inc.

3D Systems Corp. provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on demand manufacturing services, and digital design tools.

Cubic Corporation is a technology-driven, marketleading provider of integrated solutions that increase situational understanding for transportation, defense command, control, communications, computers, intelligence, surveillance, and reconnaissance (“C4ISR”), and training customers worldwide to decrease urban congestion and improve the militaries’ effectiveness and operational readiness.

Kadmon Holdings, Inc. is a biopharmaceutical company that discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. The Company’s lead product candidates include, among others, belumosudil (KD025), an orally administered selective inhibitor of ROCK2, which is in Phase II clinical development for the treatment of cGVHD.

Canoo Inc. (formerly known as Hennessy Capital Acquisition Corp. IV) was formed for the purpose of effecting a business combination with specific focus on businesses in the industrial, technology and infrastructure sectors. Such companies are referred to as “blank check” companies or special purpose acquisition companies (“SPACs”). In December 2020, the Company entered into a business combination with Canoo Holdings Limited. The combined company purports to be a mobility technology company that develops electric vehicles.

NIC, Inc. is a leading provider of digital government services that help governments use technology to provide a higher level of service to businesses and citizens and to increase efficiencies. NIC accomplishes this through two channels: its state enterprise businesses and its software & services businesses.

Repro Med Systems, Inc. d/b/a KORU Medical Systems designs, manufactures, and markets proprietary portable medical devices, primarily for the ambulatory infusion market. Much of KORU’s products are sold through four distributors, with one distributor frequently making up more than half of KORU’s net revenues.

Vroom, Inc. operates an end-to-end ecommerce platform that sells fully reconditioned vehicles. It purports to offer an “exceptional ecommerce experience” that provides customers with transparent pricing, real-time financing, and nationwide contact-free delivery.

Change Healthcare Inc. is a leading independent healthcare technology company, focused on accelerating the transformation of the healthcare system through its Change Healthcare Platform.

Lordstown Motors Corp. is an automotive company founded for the purpose of developing and manufacturing light duty electric trucks targeted for sale to fleet customers. The Company’s purported flagship vehicle is the “Endurance,” an electric full-size pickup truck.

Sequential Brands Group, Inc., together with its subsidiaries, owns various consumer brands, licenses its brands for a range of product categories, including apparel, footwear, fashion accessories, and home goods and promotes, markets, and licenses its brands through various distribution channels, including to retailers, wholesalers, and distributors.

BELLUS Health Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. Its lead product, BLU-5937, is being developed for the treatment of chronic cough and other afferent hypersensitization-related disorders.

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK